| Literature DB >> 34066770 |
Pavel V Kovyazin1, Almira Kh Bikmeeva1, Denis N Islamov1, Vasiliy M Yanybin1, Tatyana V Tyumkina1, Lyudmila V Parfenova1.
Abstract
1-Hexene transformations in the catalytic systems L2MCl2-XAlBui2 (L = Cp, M = Ti, Zr, Hf; L = Ind, rac-H4C2[THInd]2, M = Zr; X = H, Bu i) and [Cp2ZrH2]2-ClAlR2 activated by MMAO-12, B(C6F5)3, or (Ph3C)[B(C6F5)4] in chlorinated solvents (CH2Cl2, CHCl3, o-Cl2C6H4, ClCH2CH2Cl) were studied. The systems [Cp2ZrH2]2-MMAO-12, [Cp2ZrH2]2-ClAlBui2-MMAO-12, or Cp2ZrCl2-HAlBui2-MMAO-12 (B(C6F5)3) in CH2Cl2 showed the highest activity and selectivity towards the formation of vinylidene head-to-tail alkene dimers. The use of chloroform as a solvent provides further in situ dimer dimerization to give a tetramer yield of up to 89%. A study of the reaction of [Cp2ZrH2]2 or Cp2ZrCl2 with organoaluminum compounds and MMAO-12 by NMR spectroscopy confirmed the formation of Zr,Zr-hydride clusters as key intermediates of the alkene dimerization. The probable structure of the Zr,Zr-hydride clusters and ways of their generation in the catalytic systems were analyzed using a quantum chemical approach (DFT).Entities:
Keywords: density functional theory; dimerization; metal hydrides; metallocenes; nuclear magnetic resonance
Year: 2021 PMID: 34066770 PMCID: PMC8125888 DOI: 10.3390/molecules26092775
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Zirconocene-catalyzed dimerization of terminal alkenes.
Scheme 21-Hexene dimerization and oligomerization in catalytic systems A–D.
Catalytic activity and chemoselectivity of systems A and B in the reaction with 1-hexene.
| Entry | Catalytic Systems | [Zr]: [Al]: [Activator]:[1-Hexene] | Solvent | T, °C | Time, min | Alkene Conversion, % | Product Composition, % h | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zr Complex | OAC a | Activator | 4 | 5 | 6 | 7 | ||||||||
| 1 [ | [Cp2ZrH2]2 | ClAlBui2 | MMAO-12 | 1:3:30:100 | C6H5CH3 | 40 | 15 | >99 b | 86 | |||||
| 2 | ClAlBui2 | MMAO-12 | 1:3:30:400 | CH2Cl2 | 40 | 15 | >99 | 98 | 1.3 | |||||
| 3 | 180 | 98.2 | 1.8 | |||||||||||
| 4 | ClAlBui2 | MMAO-12 | 1:3:30:400 | CHCl3 | 40 | 15 | 92 | 92 | ||||||
| 5 | 60 | >99 | 98 | |||||||||||
| 6 | 105 | 97 | 1.3 | 1.6 | ||||||||||
| 7 | 180 | 9 | 12.6 | 1.4 | 2 | 75 | ||||||||
| 8 | 960 | 17 | - | 1.4 | 2.6 | 79 | ||||||||
| 9 | - | MMAO-12 | 1:30:400 | CHCl3 | 40 | 30 | 96 | 1 | 91 | 1 | ||||
| 10 | CH2Cl2 | >99 | <1 | 89 | 8 | |||||||||
| 11 | 60 | 86 | 1 | 73 | 10 | <1 | ||||||||
| 12 | 960 | 93 | <1 | 74 | 13 | 3 | 1 | |||||||
| 13 | (CH2Cl)2 | 60 | 90 | 83 | 5 | |||||||||
| 14 | 960 | 99 | 91 | 4 | 1 | |||||||||
| 15 [ | ClAlBui2 | B(C6F5)3 | 4:8:1:400 | C6H6 | 40 | 90 | 81 | 81 | ||||||
| 16 | - | B(C6F5)3 | 4:1:400 | CHCl3 | 40 | 960 | 0 | |||||||
| 17 | CH2Cl2 | 960 | 0 | |||||||||||
| 18 | ClAlBui2 | 4:16:1:400 | CHCl3 | 180 | 42 | 40 | 2 | |||||||
| 19 | 960 | 75 | 71 | 4 | ||||||||||
| 20 | CH2Cl2 | 960 | 0 | |||||||||||
| 21 [ | ClAlEt2 | (Ph3C)[B(C6F5)4] | 4:8:1:400 | C6H6 | 40 | 90 | 91 c | 86 | ||||||
| 22 | - | (Ph3C)[B(C6F5)4] | 4:1:400 | CHCl3 | 40 | 960 | 0 | |||||||
| 23 | CH2Cl2 | 960 | 0 | |||||||||||
| 24 | ClAlBui2 | 4:16:1:400 | CHCl3 | 180 | 44 | 9 | 20 | - | 15 | |||||
| 25 | 960 | 81 | 17 | 36 | 13 | 15 | ||||||||
| 26 | CH2Cl2 | 180 | >99 | 13 | 18 | 69 | ||||||||
| 27 [ | Cp2ZrCl2 | HAlBui2 | MMAO-12 | 1:3:30:100 | C6H5CH3 | 40 | 15 | >99 d | 91 | |||||
| 28 | HAlBui2 | MMAO-12 | 1:3:30:400 | CH2Cl2 | 40 | 30 | 98 | 97 | 1 | |||||
| 29 | 60 | 99 | 98 | 1 | ||||||||||
| 30 | - | 1:30:400 | CH2Cl2 | 40 | 180 | 98 | 96 | - | - | |||||
| 31 | 960 | 99 | 92 | 4 | <1 | |||||||||
| 32 | HAlBui2 | MMAO-12 | 1:3:30:1000 | CH2Cl2 | 40 | 30 | 82 | 80 | 2 | |||||
| 33 | 60 | 88 | 77 | 2 | 9 | |||||||||
| 34 | HAlBui2 | MMAO-12 | 1:3:30:400 | CHCl3 | 40 | 30 | >99 | 98 | 2 | |||||
| 35 | HAlBui2 | MMAO-12 | 1:3:30:1000 | CHCl3 | 40 | 30 | >99 | 90 | 7 | 3 | ||||
| 36 | HAlBui2 | MMAO-12 | 1:3:30:400 | CHCl3 | 20 | 180 | >99 | 97 | 2 | |||||
| 37 | - | MMAO-12 | 1:30:400 | CHCl3 | 40 | 180 | >99 | 5 | 3 | 2 | 89 | |||
| 38 | - | MMAO-12 | 1:10:400 | CHCl3 | 40 | 960 | 91 | 91 | <1 | |||||
| 39 | - | MMAO-12 | 1:30:400 | 40 | 30 | 99 | 93 | 4 | - | |||||
| 40 | 960 | 99 | 91 | 5 | 1 | |||||||||
| 41 | - | MMAO-12 | 1:30:400 | (CH2Cl)2 | 40 | 30 | 99 | 95 | 2 | |||||
| 42 | 960 | >99 | 96 | 2 | ||||||||||
| 43 [ | HAlBui2 | B(C6F5)3 | 4:16:1:1000 | C6H6 | 40 | 60 | >99 e | 93 | ||||||
| 44 | HAlBui2 | B(C6F5)3 | 4:16:1:1000 | CH2Cl2 | 40 | 60 | >99 | 99 | 1 | |||||
| 45 | CHCl3 | 60 | 83 | 82 | 1 | |||||||||
| 46 | - | B(C6F5)3 | 4:1:1000 | CH2Cl2 | 40 | 960 | 0 | |||||||
| 47 | CHCl3 | 40 | 960 | 0 | ||||||||||
| 48 [ | HAlBui2 | (Ph3C)[B(C6F5)4] | 4:16:1:1000 | C6H6 | 60 | 90 | 97 f | 67 | ||||||
| 49 | HAlBui2 | (Ph3C)[B(C6F5)4] | 4:16:1:1000 | CH2Cl2 | 20 | 180 | >99 | 92 | 6 | 2 | ||||
| 50 | 960 | 1 | 55 | 8 | 3 | 33 | ||||||||
| 51 | HAlBui2 | (Ph3C)[B(C6F5)4] | 4:16:1:1000 | CH2Cl2 | 40 | 30 | >99 g | 3 | 60 | 6 | 1 | 27 | ||
| 52 | 960 | 1 | 2 | 1 | 24 | 43 | ||||||||
| 53 | HAlBui2 | (Ph3C)[B(C6F5)4] | 4:16:1:1000 | CHCl3 | 20 | 180 | >99 | 76 | 8 | 2 | 13 | |||
| 54 | 40 | 180 | 15 | 8 | 11 | 65 | ||||||||
| 55 | 960 | 8 | 8 | 12 | 72 | |||||||||
| 56 | - | (Ph3C)[B(C6F5)4] | 4:1:1000 | CH2Cl2 | 40 | 960 | 0 | |||||||
| 57 | CHCl3 | 960 | 0 | |||||||||||
a OAC—organoaluminum compound; b hydrometalation product, 4%; saturated dimer, 2%; unsaturated methylalumination product, 8% [19]; c hydrometalation product, 5% [20]; d hydrometalation product, 5%; saturated dimer, 1%; unsaturated methylalumination product, 2%; e hydrometalation product, 3%; trimers, 3%; f oligomers, 23%; g 6-mers (29%) are identified; h wt % in the reaction mixture, determined by GC–MS of deuterolysis or hydrolysis products (the details of the GC–MS analysis is shown in Supporting Information, Figures S28 and S29).
Catalytic activity and chemoselectivity of systems Cp2MCl2-HAlBui2-activator (M = Ti, Hf) in the reaction with 1-hexene.
| Entry | Catalytic Systems | [Zr]: [Al]: [Activator]:[1-Alkene] | Solvent | T, °C | Time, min | Alkene Conversion, % | Product Composition, % d | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zr Complex | OAC | Activator | 4 | 5 | 6 | 7 | ||||||||
| 1 | Cp2TiCl2 a | HAlBui2 | MMAO-12 | 1:3:30:400 | CH2Cl2 | 40 | 60 | 80 | 20 | 34 | 4 | 15 | ||
| 2 | 180 | 91 | 17 | 44 | 5 | 20 | ||||||||
| 3 | CHCl3 | 60 | 93 | 16 | 36 | 6 | 5 | 28 | ||||||
| 4 | 960 | >99 | 5 | 4 | 41 | 11 | 7 | 30 | ||||||
| 5 | Cp2HfCl2 | HAlBui2 | MMAO-12 | 1:3:30:400 | CH2Cl2 | 40 | 120 | 84 | 2 | 53 | 20 | 6 | 2 | |
| 6 | 180 | 94 | 2 | 54 | 21 | 8 | 2 | |||||||
| 7 | 960 | 96 | - | 59 | 22 | 8 | 3 | 4 | ||||||
| 8 | MMAO-12 | 1:3:30:400 | CHCl3 | 40 | 60 | 60 | - | 42 | 15 | 3 | 1 | |||
| 9 | 120 | 74 b | - | 30 | 16 | 4 | 5 | |||||||
| 10 | 960 | >99 c | 6 | 17 | 17 | 15 | 9 | |||||||
| 11 | Cp2TiCl2 | HAlBui2 | (Ph3C)[B(C6F5)4] | 4:16:1:400 | CH2Cl2 | 40 | 960 | 0 | ||||||
| 12 | CHCl3 | 960 | 0 | |||||||||||
| 13 | Cp2HfCl2 | HAlBui2 | (Ph3C)[B(C6F5)4] | CH2Cl2 | 40 | 960 | 0 | |||||||
| 14 | CHCl3 | 960 | 0 | |||||||||||
a regioselectivity is significantly reduced due to double bond migration; b byproducts of toluene mono- (13%), di- (4%) and tri- (2%) alkylation with 1-hexene are formed; c byproducts of toluene mono- (22%), di- (7%), and tri- (4%) alkylation with 1-hexene are formed; d wt % in the reaction mixture, determined by GC–MS of deuterolysis or hydrolysis products (the details of the GC–MS analysis is shown in Supporting Information).
Catalytic activity and chemoselectivity of systems L2ZrCl2-HAlBui2-activator in the reaction with 1-hexene.
| Entry | Catalytic Systems | [Zr]: [Al]: [activator]:[1-alkene] | Solvent | T, °C | Time, min | Alkene Conversion, % | Product Composition, % e | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zr Complex | OAC | Activator | 4 | 5 | 6 | ||||||||
| 1 | (C5Me5)2ZrCl2 | HAlBui2 | MMAO-12 | 1:3:30:400 | CHCl3 | 40 | 30 | >99 a | |||||
| 2 | CH2Cl2 | 30 | |||||||||||
| 3 | Ind2ZrCl2 | HAlBui2 | MMAO-12 | 1:3:30:400 | CH2Cl2 | 40 | 30 | 19 | 11 | 5 | 2 | 1 | |
| 4 | 180 | 48 | 20 | 19 | 6 | 3 | |||||||
| 5 | 960 | 85 b | 9 | 18 | 18 | 16 | |||||||
| 6 | CHCl3 | 40 | 180 | >99 | 13 | 51 | 24 | 12 | |||||
| 7 | 960 | >99 c | 16 | 21 | 19 | 18 | |||||||
| 8 | HAlBui2 | MMAO-12 | 1:3:30:400 | CHCl3 | 40 | 30 | >99 d | 39 | 38 | 16 | 4 | ||
| 9 | CH2Cl2 | 960 | 0 | ||||||||||
a 1-hexene is completely consumed for toluene alkylation; b 6-mers (15%) and 7-mers (9%); c 6-mers (17%) and 7-mers (9%); d 6-mers (3%); e wt % in the reaction mixture, determined by GC–MS of deuterolysis or hydrolysis products (the details of the GC–MS analysis is shown in Supporting Information).
Figure 11H NMR spectrum of the system [Cp2ZrH2]2-ClAlBui2-MMAO-12 in CD2Cl2 (T = 298 K): (a) [Cp2ZrH2]:[ClAlBui2]:[MMAO-12] = 1:2:0; (b) [Cp2ZrH2]:[ClAlBui2]:[MMAO-12] = 1:2:5; (c) [Cp2ZrH2]:[ClAlBui2] [MMAO-12] = 1:0:7.
Scheme 3The reaction of Cp2ZrCl2 and [Cp2ZrH2]2 with OACs and MMAO-12.
Figure 21H NMR spectrum of systems Cp2ZrCl2-HAlBui2-MMAO-12 and [Cp2ZrH2]2-MMAO-12 in CDCl3 (T = 298 K): (a) [Cp2ZrCl2]:[HAlBui2]:[MMAO-12] = 1:4:0; (b) [Cp2ZrCl2]:[HAlBui2]:[MMAO-12]:[1-hexene] = 1:2:11:0.1; (c) [Cp2ZrH2]:[MMAO-12] = 1:12.
Scheme 4Theoretically calculated structures of isomers of complex 9.
Figure 3Optimized structures of isomers 9a and 9c.
Relative thermodynamic parameters of isomeric complexes 9.
| Complex | ∆E, Hartree | ∆EZPVE, | ∆H, | ∆G, | T∆S, |
|---|---|---|---|---|---|
| 9a | 0.000000 | 0.000000 | 0.0 | 0.0 | 2475.2 |
| 9b | 0.013103 | 0.012948 | 8.2 | 9.6 | 1139.2 |
| 9c | 0.003022 | 0.003398 | 2.4 | 3.3 | 1517.2 |
| 9d | 0.022146 | 0.023111 | 14.4 | 16.9 | 0.0 |
Calculated and experimental chemical shifts of isomeric complexes 9a–d (numbering according to Scheme 4).
| Complex | δ(H 1), ppm | δ(H 2), ppm | δ(H 3), ppm | δ(Cp), ppm |
|---|---|---|---|---|
| 9a | −4.2 | 2.9 | 2.9 | 5.9 |
| 9b | −2.3 | 1.8 | 1.8 | 6.2 |
| 9c | −3.6 | 3.7 | 3.7 | 6.2 |
| 9d | 0.7 | 0.8 | 0.8 | 6.0 |
| 9e | −1.6 | −0.4 | −0.4 | 6.1 |
| 9 (experimental) | −5.9 | −0.7 | −0.7 | 6.1 |